Breaking News Instant updates and real-time market news.

SNBR

Sleep Number

$35.54

0.66 (1.89%)

, TPX

Tempur Sealy

$53.95

0.7 (1.31%)

08:04
01/28/19
01/28
08:04
01/28/19
08:04

Sleep Number initiated with an Equal Weight at Barclays

Barclays analyst Matthew McClintock started Sleep Number with an Equal Weight rating and $36 price target. The company does not have the same easy comparisons as Tempur Sealy (TPX) and is further along in gaining the benefit of its direct-to-consumer expansion, McClintock tells investors in a research note.

SNBR

Sleep Number

$35.54

0.66 (1.89%)

TPX

Tempur Sealy

$53.95

0.7 (1.31%)

  • 29

    Jan

  • 14

    Feb

  • 06

    Mar

SNBR Sleep Number
$35.54

0.66 (1.89%)

09/19/18
WEDB
09/19/18
NO CHANGE
Target $65
WEDB
Outperform
Antidumping petition could lead to relief for mattress cos, says Wedbush
A consortium of U.S. mattress manufacturers yesterday filed an antidumping duty petition with the U.S. Department of Commerce and the U.S. ITC against foam and innerspring mattresses imported from China. In a research note to investors, Wedbush analyst Seth Basham says antidumping duties over 200% could "tip the scales" back in favor of U.S. producers of low-end U.S. mattresses like Tempur Sealy's (TPX) Sealy, but says the impact for Sleep Number (SNBR) is "more limited" with no exposure to the low-mattress segment, and that Purple (PRPL) could benefit "modestly." The analyst believes that more important for Tempur Sealy is the fate of Mattress Firm (MFRM), the largest U.S. mattress retailer, which he continues to expect to file near-term for bankruptcy.
07/26/18
PIPR
07/26/18
DOWNGRADE
Target $33
PIPR
Neutral
Sleep Number downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Sleep Number to Neutral and lowered his price target for the shares to $33 from $41. The Q2 earnings report was "inline with consensus but relatively disappointing," Keith tells investors in a research note. Despite a product line refresh, sales trends remain "surprisingly sluggish," the analyst contends. He believes this could be the result of escalating competition from low-price import mattresses and that his dynamic is "unlikely to change in any notable fashion."
07/10/18
WEDB
07/10/18
NO CHANGE
Target $65
WEDB
Outperform
Mattress sales 'soft,' Tempur Sealy likely below consensus for Q2, says Wedbush
Following checks with retailers across the U.S., Wedbush analyst Seth Basham told investors in a research note that nationwide brick-and-mortar retail mattress sales declined in the low-single digits in the second quarter, and though sales grew early in the quarter, they declined in May and June. Based on his checks, Basham says 4th of July period sales declined low-single digits to mid-single digits for B&M retailers, driven by steepening traffic declines and ASP gains, and that Tempur Sealy (TPX) specifically is likely to be below consensus for the quarter, with sales trends weakening due to elevated cannibalization rates as customers traded down to new, lower-priced products. He believes Tempur Sealy will maintain at least the low end of of its 2018 EBITDA guidance of $450M-$500M. Additionally, Basham says Sleep Number (SNBR) may be "slightly light" of consensus for the quarter, as his checks show that sales trends remained muted for the 4th of July period. The analyst has an Outperform rating and $65 price target on Tempur Sealy and a Neutral rating and $34 price target on Sleep Number.
04/20/18
RHCO
04/20/18
NO CHANGE
Target $32
RHCO
Hold
Sleep Number price target lowered to $32 from $35 at SunTrust
SunTrust analyst Keith Hughes lowered his price target on Sleep Number to $32 after the company posted a "weak" Q1, which he says increases expectation pressures for the second half of the year given that the management maintained its FY18 outlook. Hughes says the path to meeting that guidance is "difficult" despite the management's expectations of a turnaround, anticipating "heavy" buyback activity financed in part by debt being added to the balance sheet for the first time. The analyst keeps his Hold rating on Sleep Number.
TPX Tempur Sealy
$53.95

0.7 (1.31%)

01/28/19
LEHM
01/28/19
INITIATION
Target $70
LEHM
Overweight
Tempur Sealy initiated with an Overweight at Barclays
Barclays analyst Matthew McClintock started Tempur Sealy with an Overweight rating and $70 price target. The analyst believes the company's direct-to-consumer buildout will drive "substantial upside" to long-term growth and "sustainable" earnings growth above the mid-teens.
01/07/19
01/07/19
UPGRADE
Target $55

Buy
Tempur Sealy upgraded to Buy at Guggenheim
As previously reported, Guggenheim upgraded Tempur Sealy (TPX) to Buy from Neutral and established a $55 price target. Analyst Robert Drbul said risk/reward has become more attractive and the worst of Tempur's financial pressures from the January 2017 Mattress Firm (MFRM) split are behind it. DrBul believes the most logical and correct solution for Tempur is to re-engage Mattress Firm and reconcile past differences, which would be a win/win for both parties.
01/07/19
GUGG
01/07/19
UPGRADE
GUGG
Buy
Tempur Sealy upgraded to Buy from Neutral at Guggenheim
11/01/18
LOOP
11/01/18
NO CHANGE
Target $36
LOOP
Sell
Loop Capital affirms Sell rating on Tempur Sealy after Q3 miss
Loop Capital analyst Laura Champine maintains a Sell rating Tempur Sealy with a $36 price target after the company's Q3 results missed expectations on the top- and bottom-lines. The analyst is concerned that Tempur's price increases in 2019 to recapture higher commodity costs "may only encourage continued consumer trade-down in the company's range." It may be tough to convince consumers to trade up to higher-priced offerings in the Sealy line in particular given the aggressive financing offers customers rely on in the mattress industry and the influx of competing mattresses from Asia at compelling price points, Champine tells investors in a post-earnings research note.

TODAY'S FREE FLY STORIES

MAIN

Main Street

$42.50

0.23 (0.54%)

07:41
10/22/19
10/22
07:41
10/22/19
07:41
Downgrade
Main Street rating change  »

Main Street downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

, OPK

Opko Health

$2.12

0.03 (1.44%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Recommendations
Ascendis Pharma, Opko Health, Pfizer analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

OPK

Opko Health

$2.12

0.03 (1.44%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Hot Stocks
Callon Petroleum files presentation highlighting benefits of Carrizo deal »

Callon Petroleum Company…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

BAND

Bandwidth

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Bandwidth rating change  »

Bandwidth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ARCC

Ares Capital

$18.70

0.14 (0.75%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Downgrade
Ares Capital rating change  »

Ares Capital downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FRPT

Freshpet

$49.68

0.05 (0.10%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Freshpet rating change  »

JPMorgan upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 19

    Nov

  • 20

    Nov

CHCO

City Holding

$79.30

1.94 (2.51%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Earnings
City Holding reports Q3 EPS $1.36, consensus $1.32 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCC

Owl Rock

$16.90

-0.08 (-0.47%)

07:38
10/22/19
10/22
07:38
10/22/19
07:38
Downgrade
Owl Rock rating change  »

Owl Rock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:38
10/22/19
10/22
07:38
10/22/19
07:38
Hot Stocks
Paulson & Co. reiterates opposition to Carrizo deal »

Paulson & Co., as…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

LMT

Lockheed Martin

$373.16

0.54 (0.14%)

07:38
10/22/19
10/22
07:38
10/22/19
07:38
Hot Stocks
Lockheed Martin sees FY20 sales $62.0B, consensus $62.82B »

The company said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

RVNC

Revance

$15.67

0.495 (3.26%)

07:37
10/22/19
10/22
07:37
10/22/19
07:37
Conference/Events
Revance management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 21

    Nov

AAOI

Applied Optoelectronics

$10.83

-0.02 (-0.18%)

07:37
10/22/19
10/22
07:37
10/22/19
07:37
Downgrade
Applied Optoelectronics rating change  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 09

    Dec

ZION

Zions Bancorp

$45.68

0.96 (2.15%)

07:36
10/22/19
10/22
07:36
10/22/19
07:36
Recommendations
Zions Bancorp analyst commentary  »

Zions Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBIX

Ebix

$39.90

1.32 (3.42%)

07:35
10/22/19
10/22
07:35
10/22/19
07:35
Hot Stocks
Ebix facilitates $20B of premiums for Willis Accounting over last four years »

Ebix Europe announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$373.16

0.54 (0.14%)

07:35
10/22/19
10/22
07:35
10/22/19
07:35
Earnings
Lockheed Martin raises FY19 EPS view to $21.55 from $20.85-$21.15 »

Raises FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

WBS

Webster Financial

$47.31

0.39 (0.83%)

07:35
10/22/19
10/22
07:35
10/22/19
07:35
Earnings
Webster Financial reports Q3 EPS $1.00, consensus $1.01 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

CNC

Centene

$45.83

-1.09 (-2.32%)

07:35
10/22/19
10/22
07:35
10/22/19
07:35
Conference/Events
Centene management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

KR

Kroger

$24.11

0.17 (0.71%)

, JBLU

JetBlue

$17.54

0.59 (3.48%)

07:35
10/22/19
10/22
07:35
10/22/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

KR

Kroger

$24.11

0.17 (0.71%)

JBLU

JetBlue

$17.54

0.59 (3.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 10

    Nov

KMB

Kimberly-Clark

$139.31

2.01 (1.46%)

07:34
10/22/19
10/22
07:34
10/22/19
07:34
Hot Stocks
Kimberly-Clark provides update to 2018 Global Restructuring Program »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BLUE

Bluebird Bio

$91.47

1.74 (1.94%)

07:34
10/22/19
10/22
07:34
10/22/19
07:34
Hot Stocks
Bluebird Bio gets EMA approval for Zynteglo refined manufacturing specifications »

Bluebird Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

RDDTF

Radient Technologies

$0.00

(0.00%)

07:34
10/22/19
10/22
07:34
10/22/19
07:34
Hot Stocks
Radient Technologies, Edlong Corporation enter MOU to form strategic JV »

Radient Technologies and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEE

NextEra Energy

$232.85

0.17 (0.07%)

07:33
10/22/19
10/22
07:33
10/22/19
07:33
Earnings
NextEra Energy reports Q3 adjusted EPS $2.39, consensus $2.29 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 04

    Dec

JNPR

Juniper

$24.26

0.36 (1.51%)

07:33
10/22/19
10/22
07:33
10/22/19
07:33
Upgrade
Juniper rating change  »

Juniper upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 09

    Dec

ZION

Zions Bancorp

$45.68

0.96 (2.15%)

07:32
10/22/19
10/22
07:32
10/22/19
07:32
Recommendations
Zions Bancorp analyst commentary  »

Zions Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$139.31

2.01 (1.46%)

07:32
10/22/19
10/22
07:32
10/22/19
07:32
Hot Stocks
Kimberly-Clark CEO says 'we delivered excellent third quarter results' »

CEO Mike Hsu said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.